Some images has been designed using resources from Unsplash & Pixabay & Pexels & Freepik and some icons from Flaticon
跳到主要內容
:::
:::

Laboratory of Stem Cell ResearchII

TEL: +886-2-28757394
E-mail: shchiou@vghtpe.gov.tw
Principal Investigator: Shih-Hwa Chiou ,M.D Ph.D.


Education:

1999-2002   PhD, Institute of Clinical Medicine, National Yang-Ming University

1987-1994  chool of Medicine, National Defense Medical College

Key Experience:

2009  Associate professor, Institute of Pharmacology, National Yang-Ming University

2008  Co-Director, Stem Cell Center, Taipei Veterans General Hospital

2007  Visiting Researcher, Molecular Biochemistry, The Scripps Research Institute, CA, USA

2006 -  Associate professor, Medical School, National Yang-Ming University

2005 -  Attending physician, Department of Medical Research & Education, TVGH

2003-2004  Chief, the section of Ophthalmology, Tauyuan Veterans Hospital

2002-2006  Assistant professor, Medical School, National Yang-Ming University

2002  Post-Doc, City of Hope, Bone Marrow Transplant/Stem Cell Lab, CA, USA

2000-  Attending physician, Department of Ophthalmology, TVGH

1994-1999  Resident/Fellow training, Ophthalmology, Taipei Veterans General Hospital

 

Specialty:

Stem Cell、Cancer Stem Cell、Pharmacology、Ophthamology


Honor and Awards:
1999 Medical Innovation Award, Taipei Veterans General Hospital, Taiwan
2002 Best Presentation and Publication Award, Association of Asian Ophthalmologists, Japan
2003 Best Paper Award, International Stem Cell Meeting, Taipei, Taiwan.
2005 Young Investigator Award, Molecular Imaging Society, Colone, Germany
2008 Medical Innovation Award, Taipei Veterans General Hospital, Taiwan

Recent Publication:                                                                                                                               

(Selected Publications from total of 300 papers)               *: Corresponding author

  1. Ishola AA, Chien CS, Yang YP, Chien Y, Yarmishyn AA, Tsai PH, Chen JC, Hsu PK, Luo YH, Chen YM, Liang KH, Lan YT, Huo TI, Ma HI, Chen MT, Wang ML, Chiou SH*Oncogenic circRNA C190 Promotes Non-Small Cell Lung Cancer via Modulation of the EGFR/ERK Pathway. Cancer Res. 2022 Jan 1;82(1):75-89. (SCI: 12.701 ; RANK=17/242 ;ONCOLOGY
  2. Chien CS, Li Julie YS, YC, Wang ML, Aliaksandr A Yarmishyn, Tsai PH, Juan CC, Phu Neugyn, Cheng HM, Huo TI, Chiou SH *, Chien Shu * (listed as co-corresponding author).METTL3-dependent N6-methyladenosine RNA Modification Mediates the Atherogenic Inflammatory Cascades in Vascular Endothelium. Proc. Natl. Acad. Sci. USA 2021 118 (7) e2025070118 (IF= 9.412; RANK=8/71;Multidisciplinary Sciences)
  3. SJ Chou,Yang P, Ban Q, Yang YP, Wang ML, Chien CS, Chen SJ, Sun N, Zhu Y, Wang F, Zhang RY, Nguyen VQ, Liu Wnfei, Chen M, Jonas SJ, Weiss PS, Tseng HR*, Chiou SH*. Dual Supramolecular Nanoparticle Vectors Enable CRISPR/Cas9‐Mediated Knockin of Retinoschisin 1 Gene—A Potential Nonviral Therapeutic Solution for X‐Linked Juvenile Retinoschisis. Advanced Science 2020 April 16;7(10):1903432 (IF=15.804;RANK=9/103; NANOSCIENCE & NANOTECHNOLOGY )
  4. Yang P, Chou SJ, Li J, Hui W, Liu W, Sun N, Zhang RY, Zhu Y, Tsai ML, Lai HI, Smalley M, Zhang X, Chen J, Romero Z, Liu D, Ke Z, Zou C, Lee CF, Jonas SJ, Ban Q, Weiss PS*, Kohn DB*, Chen K*, Chiou SH*, Tseng HR*.Supramolecular Nanosubstrate-Mediated Delivery System Enables CRISPR/Cas9 Knockin of Hemoglobin Beta Gene for Hemoglobinopathies. Science Advances 2020 Oct 23;6(43):eabb7107  (IF=13.116;RANK=4/71; MULTIDISCIPLINARY SCIENCES)
  5. Tsai PH, Chien Y, Wang ML, Hsu CH, Laurent B, Chou SJ, Chang WC, Chien CS, Li HY, Lee HC, Huo TI, Hung JH, Chen CH, Chiou SH*.Ash2l interacts with Oct4-stemness circuitry to promote super-enhancer-driven pluripotency network. Nucleic Acids Res 2019 Sep 26. (IF= 11.147;RANK= 15/297; BIOCHEMISTRY & MOLECULAR BIOLOGY )
  6. Chen HY, Wang ML, Laurent B, Hsu CH, Chen MT, Lin LT, Shen J, Chang WC, Hsu J, Hung MC, Chen YW, Huang PI, Yang YP, Li CP, Ma HI, Chen CH, Lin WC, Chiou SH*. Musashi-1 promotes stress-induced tumor progression through recruitment of AGO2. Theranostics. 2020 Jan 1; 10(1):201-217. (IF= 8.651;RANK=10 /138; MEDICINE, RESEARCH & EXPERIMENTAL )
  7. Yang TC, Chang CY, Yarmishyn AA, Mao YS, Yang YP, Wang ML, Hsu CC, Yang HY, Hwang DK, Chen SJ, Tsai ML, Lai YH, Tzeng Y, Chang CC, Chiou SH*Carboxylated nanodiamond-mediated CRISPR-Cas9 delivery of human retinoschisis mutation into human iPSCs and mouse retina. Acta Biomater 2020 Jan 1;101:484-494 (IF= 7.151;RANK= 8/87; ENGINEERING, BIOMEDICAL )
  8. Huang KC, Wang ML, Chen SJ, Kuo JC, Wang WJ, Nhi Nguyen PN, Wahlin KJ, Lu JF, Tran AA, Shi M, Chien Y, Tsai PH, Jane WN, Chang CC, Peng CH, Schlaeger TM, Chiou SH*. Morphological and Molecular Defects in Human Three-Dimensional Retinal Organoid Model of X-Linked Juvenile Retinoschisis. Stem Cell Reports 2019 Nov 12;13(5):906-923. (IF= 6.032;RANK=5 / 29)
  9. Tsai PH, Wang ML, Chang JH, Yarmishyn AA, Nhi Nguyen PN, Chen W, Chien Y, Huo TI, Mou CY, Chiou SH*. Dual Delivery of HNF4α and Cisplatin by Mesoporous Silica Nanoparticles Inhibits Cancer Pluripotency and Tumorigenicity in Hepatoma-Derived CD133-Expressing Stem Cells. ACS Appl Mater Interfaces 2019;11(22): 19808-19818. (IF=8.758;RANK=33/314)
  10. Liang Y, Wang ML, Chien CS, Yarmishyn AA, Yang YP, Lai WY, Luo YH, Lin YT, Chen YJ, Chang PC, Chiou SH*.Highlight of Immune Pathogenic Response and Hematopathologic Effect in SARS-CoV, MERS-CoV, and SARS-Cov-2 Infection. Front Immunol. 2020 May 12;11:1022. (IF=5.085; RANK=38/158; IMMUNOLOGY )
  11. Tu YF, Chien CS, Yarmishyn AA, Lin YY, Luo YH, Lin YT, Lai WY, Yang DM, Chou SJ, Yang YP, Wang ML, Chiou SH*.A Review of SARS-CoV-2 and the Ongoing Clinical Trials. Int J Mol Sci. 2020 Apr 10;21(7):2657. (IF=4.556; RANK=74/297; BIOCHEMISTRY & MOLECULAR BIOLOGY  )
  12. Wang YJ, Larsson M, Huang WT, Chiou SH, Nicholls SJ, Chao JI, and Liu DM. The use of polymer-based nanoparticles and nanostructuredmaterials in treatment and diagnosis of cardiovasculardiseases: Recent advances and emerging designs. Progress in Polymer Science. 2016. 57;153–178.(IF=27.184;RANK= 1/89 ; POLYMER SCIENCE) (Cited in Nature medicine)
  13. Recovery of oxidative stress-induced damage in Cisd2-deficient cardiomyocytes by sustained release of ferulic acid from injectable hydrogel. Cheng YH, Lin FH, Wang CY, Hsiao CY, Chen HC, Kuo HY, Tsai TF, Chiou SH*Biomaterials 2016 Oct;103:207-18 (IF=10.273;RANK=4/87)
  14. Torchia J et al., &  Chiou SH (listed as Co-authors) & Rutka JT, Jabado N, Huang A. Integrated (epi)-Genomic Analyses Identify Subgroup-Specific Therapeutic Targets in CNS Rhabdoid Tumors. Cancer Cell. 2016 Dec 12;30(6):891-908. (IF=23.532;RANK= 7/244 ; ONCOLOGY)
  15. Hwang DK, Hsu CC, Chang KJ, Chao D, Sun CH, Jheng YC, A Yarmishyn A, Wu JC, Tsai CY, Wang ML, Peng CH, Chien KH, Kao CL, Lin TC, Woung LC, Chen SJ, Chiou SH*Artificial intelligence-based decision-making for age-related macular degeneration. Theranostics. 2019 Jan 1;9(1):232-245. (IF= 8.651;RANK= 10/318; MEDICINE, RESEARCH & EXPERIMENTAL )
  16. Yang JW, Tseng ML, Fu YM, Kang CH, Cheng YT, Tzeng CK, Chiou SH, Wu CY, Chen GY. Printable Graphene Oxide Micropatterns for a Bio-Subretinal Chip. Adv Healthc Mater. 2018;7(18): e1800365.
  17. Chien CS, Wang ML, Chu PY, Chang YL, Liu WH, Lan YT, Huang PI, Chen YW, Lo WL, Chiou SH*. Lin28B/Let-7 Regulates Expression of Oct4 and Sox2 and Reprograms Oral Squamous Cell Carcinoma Cells to a Stem-like State. Cancer Res, 2015. 75(12): p. 2553-65. (IF= 9.727;RANK=19 /244; ONCOLOGY )
  18. Jiang BH, Chen WY, Li HY, Chien Y, Chang WC, Hsieh PC, Wu P, Chen CY, Song HY, Chien CS, Sung YJ, and Chiou SH*. CHD1L regulated PARP1-driven Pluripotency and Chromatin Remodeling during the Early-stage Cell Reprogramming. Stem Cells 2015. 33(10): 2961-72. (IF= 6.022;RANK=18 /156; BIOTECHNOLOGY & APPLIED MICROBIOLOGY
  19. Su VY, Chiou SH, Lin CS, Mo MH, Yang KY. Induced Pluripotent Stem Cells Attenuate Endothelial Leakage in Acute Lung Injury via Tissue Inhibitor of Metalloproteinases-1 to Reduce Focal Adhesion Kinase Activity. Stem Cells. 2019 Dec;37(12):1516-1527. IF: 5.614
  20. Hsu CC, Chien KH, Yarmishyn AA, Buddhakosai W, Wu WJ, Lin TC, Chiou SH, Chen JT, Peng CH, Hwang DK, Chen SJ, Chang YL. Modulation of osmotic stress-induced TRPV1 expression rescues human iPSC-derived retinal ganglion cells through PKA. Stem Cell Res Ther 2019 Sep 23; 10(1):284. IF: 5.363 Rank: 32/136
  21. Su VY, Yang KY, Chiou SH, Chen NJ, Mo MH, Lin CS, Wang CT. Induced Pluripotent Stem Cells Regulate Triggering Receptor Expressed on Myeloid Cell-1 Expression and the p38 Mitogen-Activated Protein Kinase Pathway in Endotoxin-Induced Acute Lung Injury. Stem Cells 2019 May;37(5):631-639.
  22. Lu HE, Yang YP, Chen YT, Wu YR, Tsai FT, Hsieh PCH, Chiou SH*.Generation of patient-specific induced pluripotent stem cells from Leber's hereditary optic neuropathy. Stem Cell Res. 2018 31;28:56-60.
  23. Syu JP, Buddhakosai W, Chen SJ, Ke CC, Chiou SH*, Kuo WC*. Supercontinuum source-based multi-contrast optical coherence tomography for rat retina imaging. Biomed Opt Express. 2018;9(12):6132-6144.
  24. Wu YR, Wang AG, Chen YT, Yarmishyn AA, Buddhakosai W, Yang YP, Shen CN, Lee HC, Chiou SH, Peng CH, Chen SJ. Bioactivity and gene expression profiles of hiPSC-generated retinal ganglion cells in MT-ND4 mutated Leber's hereditary optic neuropathy. Exp Cell Res. 2018 Feb 2. 4827(18) 30031-4.
  25. Chou SJ, Ko YL, Yang YH, Yarmishyn AA, Wu YT, Chen CT, Lee HC, Wei YH*, Chiou SH*. Generation of two isogenic human induced pluripotent stem cell lines from a 15 year-old female patient with MERRF syndrome and A8344G mutation of mitochondrial DNA. Stem Cell Res. 2018;30:201-205.
  26. Chuang JH, Yarmishyn AA, Hwang DK, Hsu CC, Wang ML, Yang YP, Chien KH, Chiou SH, Peng CH, Chen SJ. Expression profiling of cell-intrinsic regulators in the process of differentiation of human iPSCs into retinal lineages. Stem Cell Res Ther. 2018 May 11;9(1):140.
  27. Induced pluripotent stem cells reduce neutrophil chemotaxis via activating GRK2 in endotoxin-induced acute lung injury. Su VY, Chiou SH, Lin CS, Chen WC, Yu WK, Chen YW, Chen CY, Yang KY. Respirology. 2017 Aug;22(6):1156-1164.
  28. Musashi-1 Enhances Glioblastoma Cell Migration and Cytoskeletal Dynamics through Translational Inhibition of Tensin3. Chen HY, Lin LT, Wang ML, Laurent B, Hsu CH, Pan CM, Jiang WR, Chen PY, Ma HI, Chen YW, Huang PI, Chiou A, Chiou SH*Sci Rep. 2017 Aug 18;7(1):8710.
  29. Generation of Functional Dopaminergic Neurons from Reprogramming Fibroblasts by Nonviral-based Mesoporous Silica Nanoparticles. Chang JH, Tsai PH, Wang KY, Chiou SH*, Mou CY*. Sci Rep. 2018 Jan 8; 8(1):11.
  30. Chou SJ, Yu WC, Chang YL, Chen WY, Chang WC, Chien Y, Yen JC, Liu YY, Chen SJ, Wang CY, Chen YH, Niu DM, Lin SJ, Chen JW, Chiou SH*, Leu HB*. Energy utilization of induced pluripotent stem cell-derived cardiomyocyte in Fabry disease. Int J Cardiol. 2017 Apr 1;232:255-263. (IF= 6.338)
  31. Lin TC, Hwang DK, Hsu CC, Peng CH, Wang ML, Chiou SH, Chen SJ. Protective effect of metformin against retinal vein occlusions in diabetes mellitus - A nationwide population-based study. PLoS One. 2017;12(11):e0188136.
  32. Cheng YH, Chavez E, Tsai KL, Yang KC, Kuo WT, Yang YP, Chiou SH*, Lin FH*. Effects of thermosensitive chitosan-gelatin based hydrogel containing glutathione on Cisd2-deficient chondrocytes under oxidative stress. Carbohydr Polym. 2017;173:17-27.
  33. Song HY, Chiang HC, Tseng WL, Wu P, Chien CS, Leu HB, Yang YP, Wang ML, Jong YJ, Chen CH, Yu WC, Chiou SH*. Using CRISPR/Cas9-Mediated GLA Gene Knockout as an In Vitro Drug Screening Model for Fabry Disease. Int J Mol Sci. 2016 Dec 13;17(12).
  34. Chou SJ, Tseng WL, Chen CT, Lai YF, Chien CS, Chang YL, Lee HC, Wei YH, and Chiou SH*. Impaired ROS Scavenging System in Human Induced Pluripotent Stem Cells Generated from Patients with MERRF Syndrome. Scientific Reports. 2016. 6: p. 23661.
  35. Tsai PH, Chien Y, Chuang JH, Chou SJ, Chien CH, Lai YH, Li HY, Ko YL, Chang YL, Wang CY, Liu YY, Yang CH, Tsai TF, Lee YY, and Chiou SH*, Dysregulation of Mitochondrial Functions and Osteogenic Differentiation in Cisd2-Deficient Murine Induced Pluripotent Stem Cells. Stem Cells Dev2015. (IF: 3.727)
  36. Jiang BH, Tseng WL, Li HY, Wang ML, Chang YL, Sung YJ, and Chiou SH*, Poly(ADP-Ribose) Polymerase 1: Cellular Pluripotency, Reprogramming, and Tumorogenesis. Int J Mol Sci 2015. 16: 15531-45. (IF: 2.862)
  37. Chiou SH*, Jiang BH, Yu YL, Chou SJ, Ping-Hsing Tsai, Chang WC, Chen LK, Chen LH, Yueh Chien Y, Chiou GY. Poly(ADP-ribose) Polymerase 1 Regulates Nuclear Reprogramming and Promotes iPSC Generation without c-Myc. J Exp Med. 2013 Jan. 14;210(1):85-98. (SCI:13.853; Medicine, Research & Experimental 2/112)
  38. Chiou GY, Chien CS, Wang ML, Chen MT, Yang YP, Chien Y, Chang YC, Shen CC, Chio CC, Lu KH, Ma HS, Yu YL, Chen KH, Liu DM, Miller SA, Chen YW, Huang PI, Shih YH, Hung MC, Chiou SH*Epigenetic Regulation of the MiR142-3p/ Interleukin-6 Circuit in Glioblastoma. Molecular Cell 2013 Dec 12;52(5):693-706. (SCI: 15.28)
  39. Bandey I, Chiou SH, Huang AP, Tsai JC, Tu PH. Progranulin promotes TMZ resistance of glioblastoma by orchestrating DNA repair and tumor stemness. Oncogene 2015. 34(14):1853-64. (SCI: 8.559)
  40. Chiou SH, Jang SF, Mou CY. Mesoporous silica nanoparticles: a potential platform for generation of induced pluripotent stem cells? Nanomedicine 2014;9(4):377-380 (SCI: 5.824)
  41. Chen W, Tsai PH, Hung Y, Chiou SH *, Mou CY*. A Non-Viral Cell Labeling and Differentiation Agent for Induced Pluripotent Stem Cells Based on Mesoporous Silica Nanoparticles. ACS Nano 2013;7:8423-40.(SCI: 13.700)
  42. Larssona M, Huanga WC, Hsiao MH, Wang YJ, Nyden M, Chiou SH, Liu DM. Biomedical applications and colloidal properties of amphiphilically modified chitosan hybrids. Progress in Polymer Science 2013 38;1307–1328 (IF=26.383).
  43. Cheng YH, Hung KH, Tsai TH, Lee CJ, Ku RY, Chiu AW, Chiou SH*, Liu CJ. Sustained delivery of latanoprost by thermosensitive chitosan-gelatin-based hydrogel for controlling ocular hypertension. Acta Biomaterialia. 2014;10(10):4360-6 (SCI: 7.151)
  44. Hsiao MH, Chiou SH, Larsson M, Hung KH, Liu CJ, Liu DM. A temperature- induced and shear-reversible assembly of latanoprost-loaded amphiphilic chitosan colloids: Characterization and in vivo glaucoma treatment. Acta biomaterialia 2014;10:3188-96.(SCI:7.151)
  45. Yu CC, Tsai LL, Wang ML, Yu CH, Chiou GY, Chou MY, Chiou SH*miR145 targets the SOX9/ADAM17 axis to inhibit tumor initiating cells and IL-6-mediated paracrine effects in head and neck cancer. Cancer Res. 2013 Jun 1;73(11):3425-3440. (SCI: 9.329).
  46. Li LF, Liu YY, Yang CT, Chien Y, Wang ML, Twu NF, Wang CY, Chung-Chi Huang CC, Kao KC, Hsu HS, Chiou SH*. Improvement of ventilator-induced lung injury by iPSCs-derived Conditioned Medium via Inhibiting PI3K/Akt Pathway and an IP-10-related Mechanism. Biomaterials. 2013;34:78-91. (IF=10.273)
  47. Chien Y, Liao YW, Liu DM, Lin HL, Chen SJ, Chen HL, Liang CM, Mou CY, Chiou SH*Corneal repair by human corneal keratocyte- reprogrammed iPSCs and amphiphatic carboxymethyl-hexanoyl chitosan hydrogel. Biomaterials. 2012;33(32):8003-16. (IF=10.273)
  48. Hwang WL, Yang MH, Tsai ML, Lan HY, Su SH, Yang SH, Lan YT, Chiou SH*, Wang HW*SNAIL regulates interleukin-8 expression, stem cell-like activity, and tumorigenicity of human colorectal carcinoma cells. Gastroenterology. 2011 ;141(1):279-91. (IF=20.773)
  49. Lo WL, Chien Y, Chiou GY, Tseng LM, Hsu HS, Chang YL, Lu KH, Chien CS, Chen YW, Hu FW, Yu CC, Chu PY, Chiou SH*Nuclear localization signal-enhanced RNA interference of EZH2 and Oct4 in the eradication of head and neck squamous cell carcinoma-derived cancer stem cells. Biomaterials. 2012;3693-709. (IF=10.273)
  50. Chou YT, Hsieh CH, Chiou SH, Hsu CF, Kao YR, Lee CC, Chung CH, Wang YH, Hsu HS, Pang ST, Shieh YS, Wu CW. CITED2 functions as a molecular switch of cytokine-induced proliferation and quiescence. Cell Death Differ2012;19(12):2015-28. (IF=8.849)
  51. Chiou GY, Cherng JY, Hsu HS, Wang ML, Tsai CM, Lu KH, Chien Y, Tseng LM, Huang PI, Yu CC, Hsu WH, Chiou SH*Cationic polyurethanes-short branch PEI-mediated delivery of Mir145 inhibited epithelial-mesenchymal transdifferentiation and cancer stem-like properties and in lung adenocarcinoma. J Control Release. 2012;159(2):240-50.(IF=7.633)
  52. Yang YP, Chien Y, Chiou GY, Cherng JY, Wang ML, Lo WL, Chang YL, Huang PI, Chen YW, Shih YH, Chen MT, Chiou SH*Inhibition of cancer stem cell-like properties and reduced chemoradioresistance of glioblastoma using microRNA145 with cationic polyurethane-short branch PEI. Biomaterials. 2012 Feb;33(5):1462-76. (IF=10.273)
  53. Wang ML, Pan CM, Chiou SH, Chen WH, Chang HY, Lee OK, Hsu HS, Wu CW. Oncostatin m modulates the mesenchymal-epithelial transition of lung adenocarcinoma cells by a mesenchymal stem cell-mediated paracrine effect.Cancer Research. 2012;72(22):6051-64. (SCI: 9.329).
  54. Tsai KS, Yang SH, Lei YP, Tsai CC, Chen HW, Hsu CY, Chen LL, Wang HW, Miller SA, Chiou SH, Hung MC, Hung SC. Mesenchymal stem cells promote formation of colorectal tumors in mice. Gastroenterology 2011 Sep;141(3):1046-56 (IF=20.773)
  55. Peng CH, Cherng JY, Chiou GY, Chen YC, Chien CH, Kao CL, Chang YL, Chien Y, Chen LK, Liu JH, Chen SJ, Chiou SH* Delivery of Oct4 and SirT1 with cationic polyurethanes-short branch PEI to aged retinal pigment epithelium. Biomaterials. 2011;32(34):9077-88. (IF=10.273)
  56. Li HY, Chien Y, Chen YJ, Chen SF, Chang YL, Chiang CH, Jeng SY, Chang CM, Wang ML, Chen LK, Hung SI, Huo TI, Lee SD, Chiou SH*Reprogramming induced pluripotent stem cells in the absence of c-Myc for differentiation into hepatocyte-like cells. Biomaterials. 2011 Sep;32(26):5994-6005. (IF=10.273)
  57. Lo WL, Yu CC, Chiou GY, Chen YW, Huang PI, Chien CS, Chang KW, Kao SY, Chiou SH*MicroRNA-200c attenuates tumour growth and metastasis of presumptive head and neck squamous cell carcinoma stem cells. J Pathol. 2011 ;223(4):482-95. (IF=7.585)
  58. Wang CH, Chiou SH (Co-first), Chou CP, Chen YC, Huang YJ, Peng CA. Photothermolysis of glioblastoma stem-like cells targeted by carbon nanotubes conjugated with CD133 monoclonal antibody. Nanomedicine-Nanotechnology Biology and Medicine 2011 ;7(1):69-79. (IF=6.930)
  59. Chiou SH, Wang ML, Chou YT, Chen CJ, , Chen YS, Lin TW, Hsu HS, Wu CW. Coexpression of Oct4 and Nanog enhances malignancy in lung adenocarcinoma by inducing cancer stem cell-like properties and EMT. Cancer Res. 2010 ;70:10433-44. (SCI: 9.329)
  60. Chen YW, Chen KH, Huang PI, Chen YC, Hsu HS, Chang KW, Chiou SH*Cucurbitacin I suppressed stem-like property and enhanced radiation-induced apoptosis in head and neck squamous carcinoma. Mol Cancer Ther. 2010;9:2879-92. (IF=6.107)
  61. Yang MH, Chen CL, Chau GY, Chiou SH, Su CW, Chou TY, Peng WL, Wu JC. Comprehensive analysis of the independent effect of twist and snail in promoting metastasis of hepatocellular carcinoma. Hepatology. 2009 Nov;50(5):1464-74.(IF=14.971)
  62. Chiou SH, Yu CC, Huang CY, Lin SC, Liu CJ, Tsai TH, Chou SH, Chien CS, Ku HH, Lo JF. Positive correlations of Oct-4 and Nanog in oral cancer stem-like cells and high-grade oral squamous cell carcinoma. Clin Cancer Res. 2008 Jul 1;14(13):4085-95.(IF=8.772)
  63. Yang MH, Wu MZ, Chiou SH, Chen PM, Chang SY, Liu CJ, Teng SC, Wu KJ. Direct regulation of TWIST by HIF-1alpha promotes metastasis. Nat Cell Biol. 2008;10(3):295-305. (IF=20.761)

 

Last Modified:

回到最上